类固醇治疗对IgG4相关AIP中的胰腺内分泌功能的影响:通过阿基尼因刺激测试进行评估
Mari Matsushiro1,2, Takuya Haraguchi1,2, Yuji Yamazaki1,2
1Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka 553-0003, Japan.
JCEM case reports
|March 21, 2025
概括
与IgG4相关的自身免疫性胰腺炎 (AIP) 的类固醇治疗可以暂时改善胰腺内分泌功能,并防止进一步下降,尽管存在高血糖症的风险. 这突显了AIP患者炎症,治疗和糖尿病管理之间的复杂相互作用.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 与免疫球蛋白G4 (IgG4) 相关的疾病是全身性纤维炎症性疾病.
- 自身免疫性胰腺炎 (AIP) 是IgG4相关疾病的常见表现.
- 类固醇治疗是AIP的标准,但对葡萄糖代谢和胰腺内分泌功能有复杂的影响.
研究的目的:
- 调查类固醇治疗对IgG4相关AIP和二次糖尿病患者胰腺内分泌功能的影响.
- 评估普得尼索隆在管理AIP及其相关的血糖失调方面的疗效.
主要方法:
- 一个81岁的男性患有IgG4相关的AIP和胰腺糖尿病的病例报告.
- 评估胰岛素和葡萄糖分泌通过阿尔金因刺激测试在类固醇治疗前和治疗期间.
- 在普得尼索隆治疗和剂量逐渐减少期间监测血糖控制和胰腺激素分泌.
主要成果:
- 这位患者呈现出胰岛素和葡萄糖分泌功能受损,诊断为胰腺糖尿病,这是IgG4相关AIP的次要原因.
- 最初的强化胰岛素治疗未能防止激素分泌进一步下降.
- 普雷迪尼索隆治疗 (每天35毫克) 最初增强了胰岛素和葡萄糖分泌,尽管随着剂量减少,这种效果会减弱.
- 尽管有过渡性高血糖症,但类固醇治疗似乎可以防止胰腺内分泌功能进一步恶化.
结论:
- 与IgG4相关的AIP的类固醇治疗可以暂时改善胰腺内分泌功能,可能防止进一步下降.
- 在IgG4相关的AIP中糖尿病的管理需要仔细考虑类固醇对炎症和葡萄糖代谢的双重影响.
- 需要进一步的研究来优化胰腺内分泌功能障碍在IgG4相关疾病的治疗策略.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
52
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
52
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K
01:24Chronic Pancreatitis I: Introduction
56
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
56
01:16Insulin: Dosing Regimen and Adverse Effects
134
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
134
01:23Dipeptidyl Peptidase 4 Inhibitors
148
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
148
01:17Gastritis-II: Pathophysiology
202
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
202